S&P 500   4,967.23
DOW   37,986.40
QQQ   417.41
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Stock market today: Wall Street eyes corporate earnings after last week's Big Tech selloff
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
S&P 500   4,967.23
DOW   37,986.40
QQQ   417.41
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Stock market today: Wall Street eyes corporate earnings after last week's Big Tech selloff
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
S&P 500   4,967.23
DOW   37,986.40
QQQ   417.41
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Stock market today: Wall Street eyes corporate earnings after last week's Big Tech selloff
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
S&P 500   4,967.23
DOW   37,986.40
QQQ   417.41
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Stock market today: Wall Street eyes corporate earnings after last week's Big Tech selloff
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
NYSEARCA:FMCX

FMC Excelsior Focus Equity ETF (FMCX) Price, Holdings, & News

$27.29
-0.16 (-0.58%)
(As of 04/19/2024 06:40 PM ET)
Today's Range
$27.29
$27.29
50-Day Range
$27.26
$29.03
52-Week Range
$22.86
$29.09
Volume
73 shs
Average Volume
674 shs
Market Capitalization
$87.60 million
Assets Under Management
$87.72 million
Dividend Yield
0.95%
Net Expense Ratio
0.70%

About FMC Excelsior Focus Equity ETF

The FMC Excelsior Focus Equity ETF (FMCX) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed, non-transparent fund that seeks long-term capital appreciation by targeting US-listed companies, selected using a research-intensive, bottom-up fundamental approach. The fund utilizes the Precidian non-transparent model. FMCX was launched on Apr 25, 2022 and is managed by First Manhattan.

FMCX Stock Price History

FMCX ETF News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive FMCX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FMC Excelsior Focus Equity ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
First Manhattan
Fund Name
FMC Excelsior Focus Equity ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:FMCX
Inception Date
4/25/2022
Fund Manager
Himayani Puri
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Broad Equity
Focus
Strategy
Development Level
Blended Development
Region
Global
Number of Holdings
0

Fund Statistics

Assets Under Management
$87.72 million
Average Daily Volume
$0.00
Discount/Premium
0.05%

Administrator, Advisor and Custodian

Administrator
Ultimus Fund Solutions, LLC
Advisor
First Manhattan Co.
Custodian
State Street Bank and Trust Company
Distributor
Northern Lights Distributors, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
GTS

Miscellaneous

Beta
0.92
Creation Unit
5,000
Creation Fee
$100.00
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

FMC Excelsior Focus Equity ETF Expenses

TypeFMCXStrategy ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.70%0.46%0.54%0.50%0.51%
Other Expenses0.00%0.42%0.54%0.64%0.58%
Total Expense0.70%0.61%0.70%0.74%0.70%
Fee Waiver0.00%-0.44%-0.55%-0.68%-0.57%
Net Expense0.70%0.51%0.60%0.57%0.58%

FMC Excelsior Focus Equity ETF (FMCX) Holdings


FMCX ETF - Frequently Asked Questions

How have FMCX shares performed in 2024?

FMC Excelsior Focus Equity ETF's stock was trading at $26.61 on January 1st, 2024. Since then, FMCX stock has increased by 2.6% and is now trading at $27.29.
View the best growth stocks for 2024 here
.

What does FMCX invest in?

FMC Excelsior Focus Equity ETF is a equity fund issued by First Manhattan. FMCX focuses on strategy investments. The fund's investments total to approximately $87.72 million assets under management.

What stocks does FMC Excelsior Focus Equity ETF hold?
What is the management fee for FMC Excelsior Focus Equity ETF?

FMC Excelsior Focus Equity ETF's management fee is 0.70% and has no other recorded expenses or fee waivers. The net expense ratio for FMCX is 0.70%.

How do I buy shares of FMC Excelsior Focus Equity ETF?

Shares of FMCX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:FMCX) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners